INTERIM RESULTS of A PHASE 1B STUDY (PIONEER) of AN ORAL HBF INDUCER, POCIREDIR, in SICKLE CELL DISEASE

Authors
Category Primary study
Conference29th Congress of the European Hematology Association, EHA 2024
Year 2024
This article has no abstract
Epistemonikos ID: d94487152a9fc396283e784e4f50f870aee2b297
First added on: Mar 07, 2026